Forty percent of high school students report binge eating in new CDC survey
About 40% of high school students reported binge-eating in the past month in a new CDC survey, highlighting how…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 721 articles · page 3 of 21 · fetched about 1 hour ago
Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening
Want to opt out of sharing your personal health data? You may need a notary, writes Alex Rosenblat.
Read at source →
Opinion: My daughter’s death changed how I understood the nursing shortage
Health systems invest in training, but lose early-career nurses within a few years.
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’
The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is…
Read at source →
Former FDA officials blast DOGE as ‘one of the biggest disasters in American history’
Three former FDA chiefs criticized the DOGE cuts to the agency, saying they robbed the FDA of institutional knowledge…
Read at source →
As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university
White House planned shift of research funding from universities to industry risks creating a drought in basic research,…
Read at source →
STAT+: Trump administration delays new rule that could restrict imported medicines from Canada and overseas
The Trump administration is delaying by 90 days a federal rule that could prevent Americans from obtaining prescription…
Read at source →
How consumer tech company Whoop is building for Medicare patients
Whoop's chief medical officer, said the company's work with Medicare is an opportunity to prove its ability to improve…
Read at source →
STAT+: FDA adcomm members’ ties to industry under scrutiny
New research found that nearly 40% of FDA advisory meetings held over a recent 20-year period included either a patient…
Read at source →
STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more
The FTC asked a U.S. court to hold Martin Shkreli in contempt for “flagrantly” violating a court order banning him from…
Read at source →
STAT+: The startup chasing ‘general biological intelligence’
In this edition of AI Prognosis, Brittany Trang talks to Eric Nguyen, the CEO of Radical Numerics, a startup pursuing…
Read at source →
STAT+: Sanofi avoids fine as EU accepts offer to end antitrust probe over disparaging rival vaccine
E.U. antitrust regulators accepted concessions from Sanofi to settle a probe into an allegedly “misleading” campaign…
Read at source →
New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability
A wave of clinical trials have begun to test the ability of GLP-1 weight loss drugs to quell various substance use…
Read at source →
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Lobbying groups for doctors and hospitals and trade groups are working behind the scenes on how to regulate AI in…
Read at source →
Opinion: How states can resist the potential Trump vaccine shortages
“States can serve as a last line of defense against the Trump administration’s anti-vaccine policy,” writes Joel Dodge.
Read at source →
Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
“We need more rigorous, large-scale research into the gut-brain axis across the life course,” write Holly Baines and…
Read at source →
STAT+: BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion
Humana is swapping out private equity sponsors for its CenterWell Senior Primary Care clinics. Good bye, Welsh, Carson,…
Read at source →
Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69
Helen Branswell, STAT's infectious disease reporter who earned the respect of experts and public health officials with…
Read at source →
STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds
Nearly 40% of FDA advisory committee meetings over a 20-year period included either a patient or consumer rep with…
Read at source →
STAT+: Animosity in North Carolina, and MA shooting stars
In this edition of Health Care Inc., we examine the controversy around the health plan covering North Carolina's public…
Read at source →
STAT+: Doctors are giving generously to doctors running for office
Doctors have a lot on the line in the next couple years, and they are donating big to doctors running for political…
Read at source →
STAT+: FTC demands Martin Shkreli divest his pharma stocks
The FTC asked a federal court to hold Martin Shkreli in contempt for violating a court order banning him from working…
Read at source →STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences…
Read at source →
STAT+: Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE
In this edition of STAT Health Tech: A look at a study recently published in The Lancet about Google's diagnostic…
Read at source →
How many ways can the Trump administration clamp down on international researchers?
In the span of two days last week, the Trump administration issued two sweeping announcements meant to crack down on…
Read at source →
Opinion: Lethal injection will never be the same after Christa Pike’s botched execution
“The legal and medical issues in the Christa Pike case are on a collision course,” writes bioethicist M. Sara Rosenthal.
Read at source →
STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold by…
Read at source →
Opinion: STAT+: The epidemic of learned helplessness in physicians
“Hordes of brilliant, graduate-degree-holding professionals in their 40s, 50s, and beyond act helpless at work,” writes…
Read at source →
Americans trust science more than peers around the world, survey shows
Just 40 percent of Americans reported a lot of confidence in U.S. hospitals and health clinics, the same proportion as…
Read at source →
STAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being considered for…
Read at source →
STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot
The AHA is once again suing the Trump administration over its plan to revamp a federal drug discount program into one…
Read at source →
STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds
The gifts and payments that doctors receive from drugmakers increased inappropriate prescribing, likely leading to…
Read at source →
STAT+: Medicare Advantage star ratings trigger new bonuses, and uncertainty
The federal government has released new quality ratings for Medicare Advantage insurers for 2027, with Humana emerging…
Read at source →
STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug
Life Biosciences said yesterday that three glaucoma patients have now received a single injection of its experimental…
Read at source →
How these census changes could threaten public health
The Trump administration wants to make three big changes to the U.S. Census, including eliminating questions about…
Read at source →STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more
The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx…
Read at source →